Role of integrated cancer nanomedicine in overcoming drug resistance
Author:
Publisher
Elsevier BV
Subject
Pharmaceutical Science
Reference242 articles.
1. Drug delivery systems: entering the mainstream;Allen;Science,2004
2. Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal;Tsuruo;Cancer Sci.,2003
3. Multiple drug resistance in cancer revisited: the cancer stem cell hypothesis;Donnenberg;J. Clin. Pharmacol.,2005
4. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer;Singh;Oncogene,2010
5. Randomized phase II trial of erlotinib with and without entinostat in patients with advanced non-small-cell lung cancer who progressed on prior chemotherapy;Witta;J. Clin. Oncol.,2012
Cited by 286 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A Journey of Challenges and Victories: A Bibliometric Worldview of Nanomedicine since the 21st Century;Advanced Materials;2024-01-17
2. USP22-JMJD8 axis promotes Lenvatinib resistance in hepatocellular carcinoma;Biochimica et Biophysica Acta (BBA) - Molecular Cell Research;2024-01
3. New insight into the mechanisms of Ginkgo biloba leaves in the treatment of cancer;Phytomedicine;2024-01
4. Combination therapy with Polygala tenuifolia Willd and Phellodendron chinense Schneid extracts provides effective protection against Micropterus Salmoides Rhabdovirus in largemouth bass;Aquaculture;2024-01
5. Nanoparticles Improve the Passage of Nerve Growth Factor Through Blood-Brain Barrier by Stimulating Aβ Clearance;Journal of Biomedical Nanotechnology;2024-01-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3